SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-038523
Filing Date
2023-10-27
Accepted
2023-10-27 16:15:33
Documents
13
Period of Report
2023-10-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43062
2 ex3-1.htm EX-3.1 11593
  Complete submission text file 0001493152-23-038523.txt   234838

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vvos-20231027.xsd EX-101.SCH 3006
4 XBRL LABEL FILE vvos-20231027_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE vvos-20231027_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3525
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 231355703
SIC: 3841 Surgical & Medical Instruments & Apparatus